You Searched For "biocon" and got 17 results
Sort By:
Biocon’s subsidiary raises $30 million from Tata Capital – company’s shares jump by almost 2%
Biocon’s subsidiary company Biocon Biologics has raised $30 million from Tata Capital Growth Fund, …
Biocon Q1FY23 revenue up 23% at Rs 2,217 cr
Global biopharmaceuticals company Biocon on Wednesday reported 23 per cent rise in revenue for the …
Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 billion
In addition to vaccines, the strategic alliance will also develop antibodies targeting seve…
PTI
Biocon Brings Dr Vijay Kuchroo And Dr Jeremy Levin On Board
Currently, Dr Kuchroo is the Samuel L Wasserstrom professor of Neurology at Harvard Medical School,…
True North to invest Rs 536.25 crore in Biocon Biologics for 2.44 pc stake
New Delhi, Jan 6 () Biotechnology major Biocon on Monday said private equity firm True North will i…
PTI
Biocon’s Kiran Mazumdar Shaw, who debuted in the pharma industry with two employees and $500 becomes EY World Entrepreneur of the Year 2020
With this, she has joined the likes of Uday Kotak of Kotak Mahindra Bank and Narayana Murthy of …
Biocon shares rally nearly 8 pc after Q4 earnings
New Delhi, May 24 (PTI) Shares of Biocon climbed nearly 8 per cent on Wednesday after the biotechno…
PTI
Biocon, Equillium expand licensing pact for Itolizumab to include Australia, New Zealand
New Delhi, Dec 12 () Biotechnology major Biocon and US-based biotechnology firm Equillium Inc on Th…
PTI
Biocon, Mylan get USFDA nod for pegfilgrastim drug substance licence
New Delhi, Nov 27 () Biotechnology major Biocon on Wednesday said that US health regulator has appr…
PTI
Biocon to launch drug for COVID-19 patients at ₹ 8,000 per vial
Biotechnology major Biocon on Monday said it will launch biologic drug Itolizumab for the treatme…
PTI
Biocon was a hot stock before the latest earnings— from Tata Asset Management to Baroda AMC, at least five mutual fund houses added it to their portfolio
The biopharma major with a market value of over $5 billion blamed the COVID-19 crisis for the fa…
Biocon, Mylan win patent litigation against Sanofi in US for insulin glargine device
"In October 2017, Sanofi had initiated patent infringement litigation against our NDA in the US Di…
PTI
Biocon gets 3 USFDA observations for insulin facility in Malaysia
As per the USFDA, Form 483 is issued to firm management at the conclusion of an inspection when in…
PTI
Biocon gets DCGI nod for use of Itolizumab for treatment of COVID-19 patients
"As an innovation-led biopharmaceuticals company, I am proud of the successful outcome of the pivo…
PTI
Biocon gets two observations from USFDA for Bengaluru-based API plant
The US Food and Drug Administration (USFDA) had conducted a post approval and GMP inspection of co…
PTI
Biocon gets EIR from USFDA for manufacturing facility in Bengaluru
"Biocon has received the EIR from the US Food and Drug Administration (FDA) for the post-approval …
PTI
Biocon shares are depressed itself but Syngene can offer a shot of hope
The Bengaluru-based biopharmaceutical company Biocon Limited share price fell over 3%. Investors …